This website uses cookies
Read our Privacy policy and Terms of use for more information.
Find the content you are looking for on Diabetech by searching the desired device, company, or topic.
Oct 9, 2026
•
1 min read
The glucose monitoring startup has secured new funding and partnered with Ascensia to bring its next-generation microsensor CGM to Europe.
From tubeless pumps to customizable AID systems, here’s a look at the major insulin pumps available in the U.S. and what sets each apart.
Oct 8, 2026
EARLY ACCESS: After two years of development, Trio 1.0 brings new device integrations, a rebuilt app, new features, and more flexibility to AID.
Oct 6, 2026
Biolinq’s needle-free will soon be available OTC for adults not using insulin, expanding access to continuous glucose insights without a prescription.
Tandem Diabetes' first tubeless insulin pump is expected to reach the market in 2027, creating an entirely new category of insulin pump.
Oct 5, 2026
twiist adds insulin pump control to two Android phones and smartwatches, giving more users access to the highly customizable app-controlled AID system.